Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Nardin Nakhla, Ph.D.
CTO
Simmunome Inc., Canada
Poster(s):
(M1130-02-09) Deciphering Response Patterns to AKT Inhibitor MK2206 in Breast Cancer Patients: Unveiling Signature Profiles
Monday, October 21, 2024
11:30 AM – 12:30 PM
MT
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Tuesday, October 22, 2024
11:30 AM – 12:30 PM
MT
